FEATURES OF REGULATION OF ERYTHROPOIESIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5D

FEATURES OF REGULATION OF ERYTHROPOIESIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5D

The aim: to study features of the cytokine profile in patients with chronic kidney disease receiving treatment by programmed hemodialysis. Materials and methods: the study included 100 patients aged 53,4 ± 15,8 years with chronic kidney disease stage 5D, receiving hemodialysis. All patients were per...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. S. Lapina, M. M. Batjushin, R. A. Belovolova, I. V. Sarvilina, V. N. Poganeva
Format:	Article
Language:	Russian
Published:	SINAPS LLC 2016-03-01
Series:	Архивъ внутренней медицины
Subjects:	chronic kidney disease anemia interleukin-3 interleukin-6 erythropoietin
Online Access:	https://www.medarhive.ru/jour/article/view/489
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of cytokine secretion and study of their effect on erythropoiesis in patients with malignant neoplasms with anemia of chronic disease, iron deficiency anemia, and their combination
by: V. T. Sakhin, et al.
Published: (2023-05-01)

Erythropoiesis and Iron Exchange in Burns
by: E. N. Barkova, et al.
Published: (2007-02-01)

Pathogenetic Characteristics of Anemia in Patients with Solid Tumors
by: VT Sakhin, et al.
Published: (2017-10-01)

Options for correcting nephrogenic anemia in a patient with HIV and chronic kidney disease. Case report
by: Victor V. Fomin
Published: (2024-11-01)

Pathogenetic features of anemia of chronic diseases in patients with malignant neoplasms and rheumatic pathology
by: V. T. Sakhin, et al.
Published: (2020-12-01)

Risk Factors Associated with Hyporesponsiveness to Erythropoietin in Chronic Kidney Disease Patients on Hemodialysis Who Present Anemia: A Multicenter Case-Control Study
by: Carlos Perez Tulcanaza, et al.
Published: (2025-06-01)

INTERLEUKIN-6 PROFILE IN EARLY POSTOPERATIVE PERIOD AFTER KIDNEY TRANSPLANTATION
by: A. V. Vatazin, et al.
Published: (2013-03-01)

Role of interleukins in heart failure with reduced ejection fraction
by: Oliwia Anna Segiet, et al.
Published: (2019-11-01)

THE CLINICAL AND PATHOGENETIC FEATURES OF OSTEOARTHROSIS IN WOMEN WITH DIFFERENT TYPES OF OBESITY
by: Darya Andreyevna Kopylova, et al.
Published: (2012-12-01)

Treatment of anemia of chronic kidney disease caused by ANCA associated vasculitis with roxadustat:one case report with a literature review
by: Xiao Xiang, et al.
Published: (2021-01-01)

Anemia Management Strategies in Diabetic Kidney Disease: A Comprehensive Review
by: Krishna S. Upadhye, et al.
Published: (2025-04-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
by: V. E. Kulikov, et al.
Published: (2017-09-01)

Anemia of Chronic Disease: Key Mechanisms of Pathogenesis in Patients with Malignancies and Feasible Classification Approaches
by: VT Sakhin, et al.
Published: (2019-05-01)

The role of interleukin-6 classic and trans-signaling and interleukin-11 classic signaling in gastric cancer cells
by: Josephine Runge, et al.
Published: (2024-08-01)

Clinical Comparison of Renogen, a Biosimilar Epoetin-a, with the Originator, Eprex, in Chronic Kidney Disease Anemia in Indonesia: A Preliminary Study
by: Ni Made Hustrini, et al.
Published: (2019-11-01)

Clinical Comparison of Renogen, a Biosimilar Epoetin-a, with the Originator, Eprex, in Chronic Kidney Disease Anemia in Indonesia: A Preliminary Study
by: Ni Made Hustrini, et al.
Published: (2019-11-01)

Cytokine profile in patients with early latent syphilis.
by: S. V. Zakharov
Published: (2018-04-01)

Influencing factors for hyporesponsiveness to erythropoiesis-stimulating agents in patients on maintenance hemodialysis and construction of a predictive model
by: YIN Jiaming, LUO Congjuan, SHEN Bing, YUAN Nan, SUN Lijie, CHAI Yalin
Published: (2025-08-01)

Serum IL-6 and IL-10 levels are associated with fatal outcomes in patients with SFTS in China
by: Xiaoyi Liu, et al.
Published: (2025-02-01)

The Significance of Serum and Fecal Levels of Interleukin-6 and Interleukin-8 in Hospitalized Children with Acute Rotavirus and Norovirus Gastroenteritis
by: Shan-Ming Chen, et al.
Published: (2014-04-01)

Comparison of spleen characterization and plasma levels of interleukin 6 and 10 in obese and healthy individuals
by: Mahdis Tanzifi, et al.
Published: (2024-12-01)

Influence of renin-angiotensin-aldosterone system block on the systemic inflammation activity and left ventricle remodeling in patients with Q-myocardial infarction after thrombolysis
by: S. M. Kyselov
Published: (2015-06-01)

The effect of adolescent treadmill mandatory exercise on symptoms of depression and brain inflammatory responses following maternal separation stress in mature male rats
by: F Zolfaghari, et al.
Published: (2017-12-01)

Cardiometabolic risk factors and their relationship with the interleukin-6 receptor gene polymorphism (rs2228145) in patients with hypertrophic cardiomyopathy
by: T. G. Bezhanishvili, et al.
Published: (2020-11-01)

CLINICOPATHOLOGICAL CORRELATION OF ANEMIA IN CHRONIC KIDNEY DISEASE: A CROSS-SECTIONAL STUDY IN A TERTIARY CARE HOSPITAL.
by: Dr. S Sivajyothsna, et al.
Published: (2025-03-01)

Cohort Prospective Study to Evaluate Immunogenicity of Epodion® (Biosimilar Epoetin-α) in Anemia Associated with Chronic Kidney Disease (CKD) Patients
by: Nova Angginy, et al.
Published: (2022-09-01)

Cadmium decreases human gingival fibroblast viability and induces pro-inflammatory response associated with Akt and MAPK pathway activation
by: Tipparat Parakaw, et al.
Published: (2025-07-01)

Diagnostic value of serum levels of interleukin-9,interleukin-18 and interleukin-32 in patients with multiple myeloma
by: Zhuang Ni-la, et al.
Published: (2021-01-01)

Clinical Characteristics and Outcome of Kidney Transplant Recipients Infected with COVID-19: A Retrospective Observational Study
by: Manzoor Ahmad Parry, et al.
Published: (2024-12-01)

Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6
by: Evgeny L. Nasonov, et al.
Published: (2024-09-01)

CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS
by: V. D. Nazarov, et al.
Published: (2018-01-01)

Clinical therapeutic effects of multi-target treatment on type-Ⅳ lupus nephritis and the effects on serum IL-6,IL-13,and IL-18 levels
by: ZHANG Yong, et al.
Published: (2016-01-01)

IL-6 Signaling in Immunopathology: From Basic Biology to Selective Therapeutic Intervention
by: Schumertl T, et al.
Published: (2025-07-01)

Pro-inflammatory cytokines in patients with chronic kidney disease: interleukin-6 in focus
by: I. T. Murkamilov, et al.
Published: (2019-11-01)

Serum concentrations of interleukin-6 and tumor necrosis factor alpha in patients with spondyloarthritis: a relationship between systemic inflammation and anemia
by: К. N. Safarova, et al.
Published: (2022-07-01)

Role of myokines in regulation of a power exchange
by: V. I. Scherbakov, et al.
Published: (2012-06-01)

N-acetylcysteine reduces the hepatic complications of social isolation stress through modulation of interleukin 1 and 6 gene expression and liver enzymes in mice
by: Javad Asgharzadeh, et al.
Published: (2025-07-01)

Detection of interleukin-6 and interleukin-8 in serum from women with recurrent spontaneous abortion
by: Baghdad Science Journal
Published: (2010-09-01)

A Systematic Review with Meta-Analysis and Indirect Comparison of the Effectiveness of COVID-19 Anti-Interleukin Therapy
by: Yu. M. Gomon, et al.
Published: (2023-07-01)